BACK TO ALL REFERENCES
HERMOD project: clinical study of HER-096 for the treatment of Parkinson's disease
HERMOD, short for HER-096 Motor Outcome and Disease Modification in Parkinson’s Disease, will evaluate the efficacy, safety and tolerability of HER-096 while also exploring innovative digital biomarkers that may help detect treatment effects and disease progression more sensitively, in people newly diagnosed with Parkinson’s disease.
€8 m
in funding
Key numbers
5
institutes
3
countries
About the project
HERMOD, short for HER-096 Motor Outcome and Disease Modification in Parkinson’s Disease, will evaluate the efficacy, safety and tolerability of HER-096 while also exploring innovative digital biomarkers that may help detect treatment effects and disease progression more sensitively, in people newly diagnosed with Parkinson’s disease. The study will include a 36-week double-blind, placebo-controlled period followed by a 24-week period during which all participants will receive active treatment.
Impact of the project:
HERMOD outcomes have potential to slow down or even stop the Parkinson’s disease progression. The project combines clinical evaluation with digital monitoring, biomarker analyses and imaging to assess treatment effects and disease progression.
Funding instrument Horizon Europe
Spinverse’s role
Spinverse supported Herantis in the preparation of the Horizon Europe proposal for and helped shape the project into a strong candidate for EU funding.
Having followed the progress of Herantis in advancing HER-096 as a clinical-stage asset, Spinverse recognised Horizon Europe as a strong strategic fit for the company’s next development phase. Spinverse supported the work by contributing to project framing, proposal development and overall positioning of the proposal.
Preparing a successful Horizon Europe proposal requires strong collaboration and complementary expertise. We greatly appreciated the professionalism and commitment of Spinverse throughout the HERMOD proposal preparation. Their support contributed to a successful application, and we now look forward to delivering the HERMOD project together with our consortium partners.
Supporting the UN Sustainable Development Goals
We share what we learn
Read our latest news on our references
